The CyberKnife® System Redefines Cancer Treatment in North India

0Shares

Non-invasive, high precision radiosurgery reduces treatment time to 1 – 5 days without any side-effects

SRINAGAR –  Medanta The Medicity and BLK Super Speciality Hospital in Delhi recently acquired and started treating patients with the CyberKnife® VSI Robotic Radiosurgery System, a breakthrough technology for cancer and tumor treatment, making the first-in-country CyberKnife VSI Systems in India. In a country, where cancer accounts for 8% of total deaths, this technology offers a revolution in cancer care.By enriching their therapeutic offerings in radiation oncology, Medanta – The Medicity Cancer Institute and the Roentgen-BLK Radiation Oncology Center can now provide patients treatment with the CyberKnife System and expand the patient population that can now benefit from CyberKnife radiosurgery and stereotactic body radiation therapy (SBRT) in the region.The CyberKnife®  System is US-FDA approved and CE marked non-invasive radiosurgery system for the treatment of both cancerous and non-cancerous tumors. It treats patients who have inoperable or surgically complex tumors.

The CyberKnife®-VSI Robotic Radiosurgery System offers a more effective and painless treatment option while ensuring higher patient comfort. What makes the CyberKnife®-VSI Robotic Radiosurgery System unique is its ability to deliver higher doses of radiation, with extreme accuracy, to the tumor. This ensures that there are no side effects or post-treatment complications.Patients can complete treatment in one to five days, as compared to 8-9 weeks it takes to complete a course of conventional radiation therapy. Each treatment session lasts between 15 and 45 minutes, depending on the tumor. If treatment is being delivered in stages, patients are required to return for additional treatments over several days (typically no more than five), as determined by the doctors. The procedure is painless, non-invasive, does not require the use of anesthesia and is feasible on an outpatient basis, with little or no recovery period.

“The CyberKnife System is increasingly being used as an alternative to conventional radiation therapy in situations where its targeting accuracy allows a shorter and more intense course of radiation, including radiosurgery for brain tumors. We are pleased to have introduced this innovative technology at Medanta and look forward to witnessing the benefits that the System offers, including real-time tracking with automatic correction of tumors that move throughout the body. The CyberKnife System comes as a significant development in cancer therapy for patients as well as doctors as it offer the most precise treatment option for a wide range of patients,” said Naresh Trehan, M.D., Chairman and Managing Director  of Medanta – The Medicity.”According to Dr. Tejinder Kataria, Chairperson, Medanta Division of Radiation Oncology, “CyberKnife® – VSI Robotic Radiosurgery System’s unique architecture and tracking capability, results in an extremely accurate delivery of radiation that spares surrounding healthy tissues and critical organs from damage. Unlike other treatments that have a linear plane and 2D space of working, CyberKnife®-VSI Robotic Radiosurgery System delivers beams from any angle in a 3D workspace. There are no frames fitted on patients even for brain (intracranial) lesions. Radiation oncology team at Medanta plans to focus on CyberKnife® radiosurgery for lung, liver, pancreas and prostate treatments besides head, neck and spine treatments.”According to Dr. S Hukku, President Association of Radiation Oncologists of India and Chairman, Roentgen BLK Radiation Oncology Centre BLK Hospital, “The CyberKnife® Robotic Radiosurgery System is a revolutionary development in cancer treatment.  It allows far superior reach and maneuverability to previously inaccessible and inoperable lesions such as lesions involving the spine and pancreas. For those of us who have struggled to address these problems for so long, this comes as a significant development in cancer therapy.”

The CyberKnife® Robotic Radiosurgery System

The usage procedure involves the participation of a team of specialists.   Before the procedure, the patient is imaged using a high-resolution CT scan, to determine the size, shape and location of the tumor. This image data is then digitally transferred to the CyberKnife® System’s workstation, where treatment planning begins. After this a qualified clinician uses the CyberKnife® software to generate a treatment plan which determines the desired radiation dose to ensure limitation of radiation exposure to the surrounding healthy tissue. Once the patient is comfortably positioned on the treatment table, the CyberKnife®-VSI Robotic Radiosurgery System’s computer-controlled robot slowly moves around the patient to deliver highly accurate, location specific radiation to the tumor. The CyberKnife®-VSI Robotic Radiosurgery System operates on a fully integrated closed loop system with each function working in unison to ensure the safest possible patient experience.

Be Part of Quality Journalism

Quality journalism takes a lot of time, money and hard work to produce and despite all the hardships we still do it. Our reporters and editors are working overtime in Kashmir and beyond to cover what you care about, break big stories, and expose injustices that can change lives. Today more people are reading Kashmir Observer than ever, but only a handful are paying while advertising revenues are falling fast.

ACT NOW
MONTHLYRs 100
YEARLYRs 1000
LIFETIMERs 10000

CLICK FOR DETAILS


Observer News Service

Leave a Reply

Your email address will not be published.

KO SUPPLEMENTS